Headache Research | National Headache Foundation

Evaluating Chronic Migraine Medication Overuse Strategies

May 5, 2022

Neurology Live April 30, 2022 Marco Meglio Vincent Martin, MD, president of the National Headache Foundation, discussed the MOTS trial, a non-inferiority study aimed at understanding treatment strategies with preventives for chronic migraine. Vincent Martin, MD The Medication Overuse Treatment…

Heads UP – Episode 118: Medication Overuse Treatment Strategy Trial for Migraine and Headache

April 11, 2022

Heads UP – Episode 118: Medication Overuse Treatment Strategy Trial -The idea of medication overuse and medication overuse headache can seem almost contradictory at times. It can seem like the very medicines we were instructed to take at the onset…

Pediatric Migraine Studies

March 29, 2022

A child’s mind is no place for migraine! As you know, migraine attacks can interfere with a person’s everyday life. And migraines in children can look differently from migraines in adults. This is why we wanted to make you aware…

Don’t Lose Hope: Learn About New Treatments for Migraine at the 2022 Migraine World Summit

March 14, 2022

Whether you’re new to migraine disease or have struggled with it for years, there can be moments of despair. Will this medication work? What am I doing wrong? How can I control this? Can I get back my life? In…

Heads UP – Episode 115: The Role of Genetics in Migraine

March 11, 2022

Don’t Lose Hope: Learn About New Treatments for Migraine at the 2022 Migraine World Summit

February 25, 2022

Heads UP – Episode 109: DATA Alert on Intranasal Zavegepant

January 10, 2022

New Data Alert on the Up-and-Coming Migraine Medication: Intranasal Zavegepant. While not yet approved for release, intranasal zavegepant has shown promise in some interesting and unique data points in the relief of acute migraine. What is zavegepant and what will…

Heads UP – Episode 101: Trudhesa Nasal Spray for the Acute Treatment of Migraine

September 15, 2021

Dr. Lindsay Weitzel talks to Dr. Tim Smith about the specifics of Trudhesa, the first DHE nasal spray to utilize Precision Olfactory Delivery (POD) technology. Trudhesa was just approved by the FDA. When will it be available to us? How…

Preventing Migraine Attacks: A Current Perspective

May 18, 2021

NATIONAL HEADACHE FOUNDATION SURVEY SHOWS MAJORITY OF PEOPLE WITH MIGRAINE ARE UNABLE TO CONTROL DISEASE AND DISSATISFIED WITH CURRENT PREVENTIVE TREATMENT OPTIONS 84% of people currently taking a preventive treatment wish there was a better treatment option- Migraine disease has…

National Headache Foundation Survey Shows Majority of People with Migraine are Unable to Control Disease and Dissatisfied with Current Preventive Treatment Options

May 11, 2021

The National Headache Foundation today announced findings from a new survey, Preventing Migraine Attacks: A Current Perspective, which characterizes the experiences of people living with migraine and highlights the physical and emotional barriers to preventive treatment. The survey found half (50%)…

Get Moving: Exercise Can Help Curb Migraine Attacks

March 26, 2021

By Cara Munez, HealthDay Anyone who gets frequent migraine symptoms knows the experience: the throbbing, the pain, the visual disturbances. Exercise has long been a potential way to reduce migraine triggers, but a new study suggests it could be especially…

Heads UP – Episode 89: Relivion Neuromodulation Device For Migraine Treatment

March 12, 2021

In Episode 89 of Heads UP, Dr. Timothy Smith and Dr. Lindsay Weitzel introduce us to a new non-invasive migraine treatment, Relivio. It is a brain neuromodulation device that has shown promise in treating migraine disease and a range of…

Next ›